Sinotherapeutics Inc. A Capital Reinvestment Ratio
Sinotherapeutics Inc. A capital reinvestment ratio. Sinotherapeutics Inc. A (688247) has a Capital Reinvestment Ratio of 0.44x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥95.33 Million) in capital expenditures (CN¥41.56 Million). Check Sinotherapeutics Inc. A (688247) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sinotherapeutics Inc. A (2020–2025)
Capital reinvestment ratio of Sinotherapeutics Inc. A from 2020 to 2025. This chart tracks Sinotherapeutics Inc. A's Capital Reinvestment Ratio across 6 annual periods. Also explore net asset growth rate of Sinotherapeutics Inc. A to track the company's year-over-year net asset growth rate.
Sinotherapeutics Inc. A Capital Reinvestment Ratio by Year (2020–2025)
Sinotherapeutics Inc. A capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see how efficiently does Sinotherapeutics Inc. A generate cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | CN¥95.33 Million | CN¥41.56 Million | ▼ -40.2% |
| 2024 | 0.73x | CN¥130.23 Million | CN¥94.93 Million | ▼ -75.8% |
| 2023 | 3.01x | CN¥12.96 Million | CN¥38.96 Million | ▲ +24.8% |
| 2022 | 2.41x | CN¥73.18 Million | CN¥176.34 Million | ▲ +2094.4% |
| 2021 | 0.11x | CN¥145.77 Million | CN¥16.01 Million | ▼ -39.8% |
| 2020 | 0.18x | CN¥210.04 Million | CN¥38.34 Million | — |